70 days, p=0.0015). Tracheal involvement, pre-treatment C-reactive protein level, and initial prednisolone monotherapy were ... Initial combination therapy with prednisolone and immunosuppressants may delay recurrence. ... and initial prednisolone monotherapy (HR 4.443 [1.515−16.267], p=0.0056) may be associated with recurrence. The median time ... The median prednisolone dose at the initial recurrence was 10 [5−12.75] mg/day. Tracheal involvement was significantly more ...
We showed evidence that co-medication with dexamethasone/prednisolone and/or estramustine itself can induce an initial PSA ...
Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in ... systemic and enteric-coated corticosteroids by demonstrating a lack of relapse in patients who were switched from prednisolone ...
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating ...
... a handheld NIR spectrometer in prediction of drug content in inkjet printed orodispersible formulations containing prednisolone ...
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and ...
Topical corticosteroid eye drops, such as 0.1% dexamethasone and 1% prednisolone acetate, are commonly applied for two to four ... compared efficacy and safety between single subtenon 40- and 25-mg triamcinolone injection with 1% prednisolone acetate eye ...